[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Mundy, 1978 - Google Patents

Calcium and cancer

Mundy, 1978

Document ID
2457783674330281663
Author
Mundy G
Publication year
Publication venue
Life Sciences

External Links

Snippet

Tumors cause disturbances in calcium homeostasis less frequently than they cause abnormalities in bone metabolism. The bone abnormalities include osteolytic metastases and osteoblastic metastases which lead to increased bone formation. Cancer is associated …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S514/00—Drug, bio-affecting and body treating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Mundy Calcium and cancer
Balsan et al. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1, 25-dihydroxyvitamin D.
Au et al. Restoration of Parathyroid Responsiveness in Vitamin D—Deficient Rats by Parenteral Calcium or Dietary Lactose
Chattopadhyay et al. Lack of suppressor cell activity in rheumatoid synovial lymphocytes.
Forte et al. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3', 5'-monophosphate excretion.
Stewart et al. Increased serum levels of anti-elastin antibodies in patients with Peyronie’s disease
Kondo et al. Association of hypercalcemia with tumors producing colony-stimulating factor (s)
KR20000062403A (en) Method of treating prostatic diseases using active vitamin D analogues
Singer et al. Paget's disease of bone
EP0202276A1 (en) Composition for the treatment of psoriasis.
Schweitzer et al. Management of severe hypercalcemia caused by primary hyperparathyroidism
Cinader et al. Immunotherapy of a patient with choriocarcinoma
Stoll Effect of Lyndiol, an oral contraceptive, on breast cancer.
Jacobs et al. Neoplastic hypercalcemia: physiologic response to intravenous etidronate disodium
Cohn et al. The spectrum of metabolic bone disease in lymphoblastic leukemia
Rasmuson et al. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma
Knazek et al. Indomethacin causes a simultaneous decrease of both prolactin binding and fluidity of mouse liver membranes
JP2002532553A (en) Use of ether lysophospholipids as potential anti-inflammatory agents without causing adverse gastrointestinal side effects
Goldyne Prostaglandins and the modulation of immunological responses.
Wright et al. Chemotherapy of disseminated carcinoma of the breast
Malachi et al. Prostaglandin E 2 and cyclic AMP in tumor and plasma of breast cancer patients
Clement et al. Giant cell arteritis of the breast: case report and literature review
Mundy et al. Osteoclast activating factor: its role in myeloma and other types of hypercalcaemia of malignancy
MUNSON Thyrocalcitonin
Adami et al. Sequential treatment of paget's disease with human calcitonin and dichloromethylene diphosphonate (CI2MDP)